3-(2,2,2-trimethylhydrazine)propionate has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apukhtin, AF; Inozemtseva, MA; Poletaeva, LV; Statsenko, ME; Turkina, SV | 1 |
| Apukhtin, AF; Dudchenko, GP; Poletaeva, LV; Statsenko, ME; Turkina, SV | 1 |
2 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
[Clinical efficiency of milrdonate in combined treatment of peripheral diabetic (sensory-motor) neuropathy].
Topics: Adjuvants, Immunologic; Aged; Diabetic Neuropathies; Dose-Response Relationship, Drug; Electromyography; Female; Humans; Male; Methylhydrazines; Middle Aged; Quality of Life; Treatment Outcome | 2008 |
[Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy].
Topics: Aged; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fasting; Female; Humans; Male; Methylhydrazines; Middle Aged; Oxidative Stress | 2008 |